Dr. Brian Wolf, MD

NPI: 1407247307
Total Payments
$11,104
2024 Payments
$2,726
Companies
57
Transactions
423
Medicare Patients
3,412
Medicare Billing
$361,550

Payment Breakdown by Category

Food & Beverage$10,918 (98.3%)
Other$158.66 (1.4%)
Education$27.64 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $10,918 414 98.3%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $158.66 7 1.4%
Education $27.64 2 0.2%

Top Paying Companies

Company Total Records Latest Year
UCB, Inc. $2,007 69 $0 (2024)
Sunovion Pharmaceuticals Inc. $770.24 34 $0 (2021)
ABBVIE INC. $717.05 38 $0 (2024)
SK Life Science, Inc. $691.27 17 $0 (2024)
CATALYST PHARMACEUTICALS, INC. $667.60 16 $0 (2024)
Eisai Inc. $529.62 16 $0 (2024)
GE HEALTHCARE $413.26 15 $0 (2024)
NEUROPACE, INC. $382.45 3 $0 (2024)
Amgen Inc. $310.31 16 $0 (2022)
Neurocrine Biosciences, Inc. $306.69 12 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,726 98 CATALYST PHARMACEUTICALS, INC. ($597.92)
2023 $2,100 79 UCB, Inc. ($826.02)
2022 $1,259 54 Neurelis, Inc. ($119.59)
2021 $1,028 31 SK Life Science, Inc. ($241.93)
2020 $1,181 47 SK Life Science, Inc. ($264.69)
2019 $1,382 77 UCB, Inc. ($193.52)
2018 $570.93 19 PORTOLA PHARMACEUTICALS, INC. ($157.16)
2017 $855.90 18 Sunovion Pharmaceuticals Inc. ($335.00)

All Payment Transactions

423 individual payment records from CMS Open Payments — Page 1 of 17

Date Company Product Nature Form Amount Type
12/19/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $18.93 General
Category: Central Nervous System
12/11/2024 CATALYST PHARMACEUTICALS, INC. FYCOMPA (Drug) Food and Beverage Cash or cash equivalent $40.02 General
Category: NEUROLOGY
12/03/2024 UCB, Inc. Fintepla (Drug) Food and Beverage In-kind items and services $44.64 General
Category: Neurology
12/03/2024 UCB, Inc. Nayzilam (Drug) Food and Beverage In-kind items and services $9.30 General
Category: Neurology
12/02/2024 ABBVIE INC. BOTOX (Biological), QULIPTA Food and Beverage In-kind items and services $28.57 General
Category: BOTOX THERAPEUTIC
11/26/2024 CSL Behring Hizentra (Biological) Food and Beverage In-kind items and services $30.76 General
Category: Immunology
11/11/2024 JAZZ PHARMACEUTICALS INC. EPIDIOLEX (Drug) Food and Beverage In-kind items and services $27.41 General
Category: NEUROLOGY
11/06/2024 CATALYST PHARMACEUTICALS, INC. FYCOMPA (Drug) Food and Beverage Cash or cash equivalent $121.84 General
Category: NEUROLOGY
11/05/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $24.90 General
Category: PSYCHIATRY
11/05/2024 UCB, Inc. Nayzilam (Drug) Food and Beverage In-kind items and services $9.70 General
Category: Neurology
11/04/2024 ARGENX US, INC. VYVGART (Drug), VYVGART HYTRULO Food and Beverage In-kind items and services $31.07 General
Category: Immunology
10/31/2024 UCB, Inc. Food and Beverage In-kind items and services $28.52 General
10/31/2024 ABBVIE INC. VYALEV (Drug), DUOPA Food and Beverage In-kind items and services $20.46 General
Category: NEUROSCIENCE
10/30/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $24.61 General
Category: PAIN
10/29/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $26.82 General
Category: NEUROSCIENCE
10/23/2024 Kyowa Kirin, Inc. Nourianz (Drug) Food and Beverage In-kind items and services $18.74 General
Category: Adenosine A2A Receptors
10/21/2024 Neurelis, Inc. VALTOCO (Drug) Food and Beverage In-kind items and services $20.32 General
Category: EPILEPSY
10/16/2024 Eisai Inc. Leqembi (Drug) Food and Beverage In-kind items and services $25.67 General
Category: Neurology
10/16/2024 UCB, Inc. Briviact (Drug) Food and Beverage In-kind items and services $11.96 General
Category: Neurology
10/14/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $9.42 General
Category: NEUROSCIENCE
10/01/2024 Amneal Pharmaceuticals LLC ONGENTYS (Drug) Food and Beverage In-kind items and services $15.81 General
Category: NEUROLOGY
09/25/2024 GE HEALTHCARE Food and Beverage In-kind items and services $31.09 General
09/24/2024 NEUROPACE, INC. RNS Neurostimulator Kit (Device) Food and Beverage In-kind items and services $132.08 General
Category: Epilepsy
09/23/2024 PFIZER INC. OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA Food and Beverage In-kind items and services $21.80 General
Category: IMMUNOLOGY
09/18/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $12.25 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 1,005 1,182 $265,287 $102,654
2022 15 982 1,130 $274,220 $102,636
2021 12 720 884 $260,004 $86,215
2020 17 705 830 $166,328 $70,046
Total Patients
3,412
Total Services
4,026
Medicare Billing
$361,550
Procedure Codes
57

All Medicare Procedures & Services

57 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 231 236 $66,788 $24,022 36.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 256 370 $55,870 $22,934 41.0%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 148 194 $41,322 $18,271 44.2%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 81 81 $33,615 $10,575 31.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 44 46 $13,524 $6,006 44.4%
95816 Measurement of brain wave activity (eeg), awake and drowsy Facility 2023 92 94 $11,092 $4,059 36.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 33 33 $10,989 $4,050 36.9%
95720 Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional Facility 2023 17 25 $10,700 $4,021 37.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 37 37 $8,103 $3,557 43.9%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 19 19 $7,999 $3,156 39.5%
95819 Measurement of brain wave activity (eeg), awake and asleep Facility 2023 36 36 $4,284 $1,565 36.5%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 11 11 $1,001 $438.80 43.8%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 191 244 $53,676 $19,624 36.6%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 168 171 $49,237 $17,842 36.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 166 247 $37,297 $15,559 41.7%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 89 90 $37,350 $13,407 35.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 59 59 $19,647 $6,774 34.5%
99220 Initial hospital observation care per day, typically 70 minutes Facility 2022 48 48 $18,192 $6,651 36.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 38 38 $11,172 $4,875 43.6%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 26 26 $10,946 $3,935 35.9%
95720 Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional Facility 2022 12 22 $9,416 $3,639 38.6%
95816 Measurement of brain wave activity (eeg), awake and drowsy Facility 2022 83 83 $9,794 $3,560 36.4%
99219 Initial hospital observation care per day, typically 50 minutes Facility 2022 23 23 $6,394 $2,422 37.9%
95819 Measurement of brain wave activity (eeg), awake and asleep Facility 2022 36 36 $4,284 $1,635 38.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 12 12 $2,628 $1,209 46.0%

About Dr. Brian Wolf, MD

Dr. Brian Wolf, MD is a Neurology healthcare provider based in Sarasota, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/12/2015. The National Provider Identifier (NPI) number assigned to this provider is 1407247307.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Wolf, MD has received a total of $11,104 in payments from pharmaceutical and medical device companies, with $2,726 received in 2024. These payments were reported across 423 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($10,918).

As a Medicare-enrolled provider, Wolf has provided services to 3,412 Medicare beneficiaries, totaling 4,026 services with total Medicare billing of $361,550. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Location Sarasota, FL
  • Active Since 02/12/2015
  • Last Updated 03/31/2023
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • NPI Number 1407247307

Products in Payments

  • Briviact (Drug) $910.73
  • APTIOM (Drug) $692.42
  • FYCOMPA (Drug) $565.52
  • Fycompa (Drug) $423.44
  • NURTEC ODT (Drug) $331.97
  • Aimovig (Biological) $310.31
  • Fintepla (Drug) $307.57
  • Nayzilam (Drug) $303.96
  • QULIPTA (Drug) $258.37
  • RNS System (Device) $250.37
  • INGREZZA (Drug) $236.00
  • XCOPRI (Drug) $230.75
  • Epidiolex (Drug) $222.19
  • INBRIJA (Drug) $208.17
  • VALTOCO (Drug) $207.87
  • BOTOX (Biological) $205.82
  • UBRELVY (Drug) $199.89
  • GOCOVRI (Drug) $192.15
  • Vimpat (Drug) $185.51
  • AIMOVIG (Biological) $176.53

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Sarasota